Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism

Majid Moshirfar,1– 3 Nour Bundogji,4 Alyson N Tukan,4 James H Ellis,5 Shannon E McCabe,1,6 Ayesha Patil,5 Yasmyne C Ronquillo,1 Phillip C Hoopes1 1Hoopes Vision Research Center, Hoopes Vision, Draper, UT, 84020, USA; 2John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, U...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Moshirfar M, Bundogji N, Tukan AN, Ellis JH, McCabe SE, Patil A, Ronquillo YC, Hoopes PC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	toric icl visian myopic astigmatism visual outcomes Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/33d12332319e463fbdad1a815afa5790
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:33d12332319e463fbdad1a815afa5790
record_format	dspace
spelling	oai:doaj.org-article:33d12332319e463fbdad1a815afa57902021-12-02T18:17:27ZToric Implantable Collamer Lens for the Treatment of Myopic Astigmatism1177-5483https://doaj.org/article/33d12332319e463fbdad1a815afa57902021-07-01T00:00:00Zhttps://www.dovepress.com/toric-implantable-collamer-lens-for-the-treatment-of-myopic-astigmatis-peer-reviewed-fulltext-article-OPTHhttps://doaj.org/toc/1177-5483Majid Moshirfar,1– 3 Nour Bundogji,4 Alyson N Tukan,4 James H Ellis,5 Shannon E McCabe,1,6 Ayesha Patil,5 Yasmyne C Ronquillo,1 Phillip C Hoopes1 1Hoopes Vision Research Center, Hoopes Vision, Draper, UT, 84020, USA; 2John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA; 3Utah Lions Eye Bank, Murray, UT, USA; 4University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA; 5University of Utah School of Medicine, Salt Lake City, UT, USA; 6Mission Hills Eye Center, Pleasant Hill, CA, USACorrespondence: Majid MoshirfarMedical Director Hoopes Vision Research Center, Hoopes Vision Research Center, 11820 S. State Street Suite #200, Draper, UT, 84020, USATel +1 801-568-0200Fax +1 801-563-0200Email cornea2020@me.comPurpose: To report visual outcomes following surgical correction of myopic astigmatism with Visian Toric implantable collamer lens (ICL) (STAAR Surgical, Monrovia, CA, USA) at a single tertiary refractive center in the United States.Patients and Methods: Toric ICL was implanted in 96 eyes (55 patients) with mean preoperative sphere of − 8.98 ± 3.04 diopters (D) and cylinder of − 2.67 ± 1.02 D from December 2018 to February 2021. Primary visual outcomes of efficacy, safety, stability, predictability of refractive correction, and astigmatic analysis were reported at three and twelve months postoperatively. Secondary subjective outcomes included patient-reported dry eye symptoms and glare/halos at postoperative visits. Other secondary outcomes were biometric data and postoperative vault over time.Results: At three and twelve months, 75 and 46 eyes were evaluated, respectively. At twelve months, the mean manifest refraction spherical equivalent (MRSE) was − 0.23 ± 0.47 D with 93% achieving within ± 1.00 D of target refraction. The manifest refractive cylinder (MRC) at twelve months was − 0.73 ± 0.51 D, with 86% within ± 1.00 D of target. Uncorrected distance visual acuity (UDVA) was 20/20 or better in 74% of eyes at twelve months. No patients lost ≥ 2 lines of corrected distance visual acuity (CDVA) at twelve months. The mean angle of error was − 0.9 ± 10.2° at three months and − 1.6 ± 12.8° at twelve months. One patient required bilateral lens rotation, four patients underwent secondary enhancement with LASIK/PRK, and seven patients underwent postoperative limbal relaxing incisions.Conclusion: This initial single-site experience finds Toric ICL implantation for myopic astigmatism to be safe and effective. Patients can achieve markedly improved UDVA in a single surgery with stable vision over time and minimal adverse subjective symptoms.Keywords: Toric ICL, visian, myopic astigmatism, visual outcomesMoshirfar MBundogji NTukan ANEllis JHMcCabe SEPatil ARonquillo YCHoopes PCDove Medical Pressarticletoric iclvisianmyopic astigmatismvisual outcomesOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 2893-2906 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	toric icl visian myopic astigmatism visual outcomes Ophthalmology RE1-994
spellingShingle	toric icl visian myopic astigmatism visual outcomes Ophthalmology RE1-994 Moshirfar M Bundogji N Tukan AN Ellis JH McCabe SE Patil A Ronquillo YC Hoopes PC Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism
description	Majid Moshirfar,1– 3 Nour Bundogji,4 Alyson N Tukan,4 James H Ellis,5 Shannon E McCabe,1,6 Ayesha Patil,5 Yasmyne C Ronquillo,1 Phillip C Hoopes1 1Hoopes Vision Research Center, Hoopes Vision, Draper, UT, 84020, USA; 2John A. Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT, USA; 3Utah Lions Eye Bank, Murray, UT, USA; 4University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA; 5University of Utah School of Medicine, Salt Lake City, UT, USA; 6Mission Hills Eye Center, Pleasant Hill, CA, USACorrespondence: Majid MoshirfarMedical Director Hoopes Vision Research Center, Hoopes Vision Research Center, 11820 S. State Street Suite #200, Draper, UT, 84020, USATel +1 801-568-0200Fax +1 801-563-0200Email cornea2020@me.comPurpose: To report visual outcomes following surgical correction of myopic astigmatism with Visian Toric implantable collamer lens (ICL) (STAAR Surgical, Monrovia, CA, USA) at a single tertiary refractive center in the United States.Patients and Methods: Toric ICL was implanted in 96 eyes (55 patients) with mean preoperative sphere of − 8.98 ± 3.04 diopters (D) and cylinder of − 2.67 ± 1.02 D from December 2018 to February 2021. Primary visual outcomes of efficacy, safety, stability, predictability of refractive correction, and astigmatic analysis were reported at three and twelve months postoperatively. Secondary subjective outcomes included patient-reported dry eye symptoms and glare/halos at postoperative visits. Other secondary outcomes were biometric data and postoperative vault over time.Results: At three and twelve months, 75 and 46 eyes were evaluated, respectively. At twelve months, the mean manifest refraction spherical equivalent (MRSE) was − 0.23 ± 0.47 D with 93% achieving within ± 1.00 D of target refraction. The manifest refractive cylinder (MRC) at twelve months was − 0.73 ± 0.51 D, with 86% within ± 1.00 D of target. Uncorrected distance visual acuity (UDVA) was 20/20 or better in 74% of eyes at twelve months. No patients lost ≥ 2 lines of corrected distance visual acuity (CDVA) at twelve months. The mean angle of error was − 0.9 ± 10.2° at three months and − 1.6 ± 12.8° at twelve months. One patient required bilateral lens rotation, four patients underwent secondary enhancement with LASIK/PRK, and seven patients underwent postoperative limbal relaxing incisions.Conclusion: This initial single-site experience finds Toric ICL implantation for myopic astigmatism to be safe and effective. Patients can achieve markedly improved UDVA in a single surgery with stable vision over time and minimal adverse subjective symptoms.Keywords: Toric ICL, visian, myopic astigmatism, visual outcomes
format	article
author	Moshirfar M Bundogji N Tukan AN Ellis JH McCabe SE Patil A Ronquillo YC Hoopes PC
author_facet	Moshirfar M Bundogji N Tukan AN Ellis JH McCabe SE Patil A Ronquillo YC Hoopes PC
author_sort	Moshirfar M
title	Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism
title_short	Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism
title_full	Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism
title_fullStr	Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism
title_full_unstemmed	Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism
title_sort	toric implantable collamer lens for the treatment of myopic astigmatism
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/33d12332319e463fbdad1a815afa5790
work_keys_str_mv	AT moshirfarm toricimplantablecollamerlensforthetreatmentofmyopicastigmatism AT bundogjin toricimplantablecollamerlensforthetreatmentofmyopicastigmatism AT tukanan toricimplantablecollamerlensforthetreatmentofmyopicastigmatism AT ellisjh toricimplantablecollamerlensforthetreatmentofmyopicastigmatism AT mccabese toricimplantablecollamerlensforthetreatmentofmyopicastigmatism AT patila toricimplantablecollamerlensforthetreatmentofmyopicastigmatism AT ronquilloyc toricimplantablecollamerlensforthetreatmentofmyopicastigmatism AT hoopespc toricimplantablecollamerlensforthetreatmentofmyopicastigmatism
_version_	1718378266286358528

Toric Implantable Collamer Lens for the Treatment of Myopic Astigmatism

Ejemplares similares